These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22579489)

  • 41. Doping control analysis of insulin and its analogues in equine urine by liquid chromatography-tandem mass spectrometry.
    Ho EN; Wan TS; Wong AS; Lam KK; Stewart BD
    J Chromatogr A; 2011 Feb; 1218(8):1139-46. PubMed ID: 21256494
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A general screening method for doping agents in human urine by solid phase extraction and liquid chromatography/time-of-flight mass spectrometry.
    Kolmonen M; Leinonen A; Pelander A; Ojanperä I
    Anal Chim Acta; 2007 Feb; 585(1):94-102. PubMed ID: 17386652
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of metabolites of adonifoline, a hepatotoxic pyrrolizidine alkaloid, by liquid chromatography/tandem and high-resolution mass spectrometry.
    Xiong A; Yang L; He Y; Zhang F; Wang J; Han H; Wang C; Bligh SW; Wang Z
    Rapid Commun Mass Spectrom; 2009 Dec; 23(24):3907-16. PubMed ID: 19918941
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Detection in urine of 4-methyl-2-hexaneamine, a doping agent.
    Perrenoud L; Saugy M; Saudan C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Nov; 877(29):3767-70. PubMed ID: 19800302
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Determination of nandrolone metabolites in human urine: comparison between liquid chromatography/tandem mass spectrometry and gas chromatography/mass spectrometry.
    Buiarelli F; Giannetti L; Jasionowska R; Cruciani C; Neri B
    Rapid Commun Mass Spectrom; 2010 Jul; 24(13):1881-94. PubMed ID: 20533318
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analysis of tolvaptan and its metabolites in sports drug testing by high-performance liquid chromatography coupled to tandem mass spectrometry.
    Rzeppa S; Viet LN
    Drug Test Anal; 2016 Oct; 8(10):1090-1094. PubMed ID: 26768215
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recent advances of liquid chromatography-(tandem) mass spectrometry in clinical and forensic toxicology.
    Peters FT
    Clin Biochem; 2011 Jan; 44(1):54-65. PubMed ID: 20709050
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An electrospray ionisation tandem mass spectrometric investigation of selected psychoactive pharmaceuticals and its application in drug and metabolite profiling by liquid chromatography/electrospray ionisation tandem mass spectrometry.
    Doherty B; Rodriguez V; Leslie JC; McClean S; Smyth WF
    Rapid Commun Mass Spectrom; 2007; 21(13):2031-8. PubMed ID: 17534857
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metabonomics investigation of human urine after ingestion of green tea with gas chromatography/mass spectrometry, liquid chromatography/mass spectrometry and (1)H NMR spectroscopy.
    Law WS; Huang PY; Ong ES; Ong CN; Li SF; Pasikanti KK; Chan EC
    Rapid Commun Mass Spectrom; 2008 Aug; 22(16):2436-46. PubMed ID: 18634125
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fast analysis of doping agents in urine by ultra-high-pressure liquid chromatography-quadrupole time-of-flight mass spectrometry. II: Confirmatory analysis.
    Badoud F; Grata E; Perrenoud L; Saugy M; Rudaz S; Veuthey JL
    J Chromatogr A; 2010 Jun; 1217(25):4109-19. PubMed ID: 19939397
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of bupropion urinary metabolites by liquid chromatography/mass spectrometry.
    Petsalo A; Turpeinen M; Tolonen A
    Rapid Commun Mass Spectrom; 2007; 21(16):2547-54. PubMed ID: 17639567
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New Potential Biomarker for Methasterone Misuse in Human Urine by Liquid Chromatography Quadrupole Time of Flight Mass Spectrometry.
    Zhang J; Lu J; Wu Y; Wang X; Xu Y; Zhang Y; Wang Y
    Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669235
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Profiling of steroid metabolites after transdermal and oral administration of testosterone by ultra-high pressure liquid chromatography coupled to quadrupole time-of-flight mass spectrometry.
    Badoud F; Boccard J; Schweizer C; Pralong F; Saugy M; Baume N
    J Steroid Biochem Mol Biol; 2013 Nov; 138():222-35. PubMed ID: 23796409
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combination of liquid-chromatography tandem mass spectrometry in different scan modes with human and chimeric mouse urine for the study of steroid metabolism.
    Pozo OJ; Lootens L; Van Eenoo P; Deventer K; Meuleman P; Leroux-Roels G; Parr MK; Schänzer W; Delbeke FT
    Drug Test Anal; 2009 Nov; 1(11-12):554-67. PubMed ID: 20355172
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Doping control analysis of metamfepramone and two major metabolites using liquid chromatography-tandem mass spectrometry.
    Thevis M; Sigmund G; Thomas A; Gougoulidis V; Rodchenkov G; Schänzer W
    Eur J Mass Spectrom (Chichester); 2009; 15(4):507-15. PubMed ID: 19661559
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Detection of bazedoxifene, a selective estrogen receptor modulator, in human urine by liquid chromatography-tandem mass spectrometry.
    Okano M; Sato M; Kageyama S
    Drug Test Anal; 2022 Nov; 14(11-12):1995-2001. PubMed ID: 35043573
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Investigation of the in vitro metabolism of the emerging drug candidate S107 for doping-preventive purposes.
    Beuck S; Schänzer W; Thevis M
    J Mass Spectrom; 2011 Feb; 46(2):112-30. PubMed ID: 21254313
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Determination of N-desmethyl- and N-bisdesmethyl metabolites of Sibutramine in doping control analysis using liquid chromatography-tandem mass spectrometry.
    Thevis M; Sigmund G; Schiffer AK; Schänzer W
    Eur J Mass Spectrom (Chichester); 2006; 12(2):129-36. PubMed ID: 16723754
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Searching for in silico predicted metabolites and designer modifications of (cortico)steroids in urine by high-resolution liquid chromatography/time-of-flight mass spectrometry.
    Peters RJ; van Engelen MC; Touber ME; Georgakopoulus C; Nielen MW
    Rapid Commun Mass Spectrom; 2009 Aug; 23(15):2329-37. PubMed ID: 19575408
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detection of main urinary metabolites of β2-agonists clenbuterol, salbutamol and terbutaline by liquid chromatography high resolution mass spectrometry.
    Domínguez-Romero JC; García-Reyes JF; Martínez-Romero R; Martínez-Lara E; Del Moral-Leal ML; Molina-Díaz A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Apr; 923-924():128-35. PubMed ID: 23500357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.